Sharing information about cancer with one's family is associated with improved quality of life

Lai, Carlo; Borrelli, Beatrice; Ciurluini, Paola; Aceto, Paola

doi:10.1002/pon.4334

Cited by 11 publications

(16 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, a previous study showed that bladder cancer diagnosis did not significantly affect the patients’ levels of anxiety and depression [28], thus suggesting that QoL may not be significantly influenced by these issues in bladder cancer patients. Also, little attention has been paid to the psychosocial issues of the patients and the importance of these in relation to a person’s QoL, which ultimately could explain the reported levels of QoL in the different domains [29]. These issues are described in the literature in the general cancer population [30–33].…”

Section: Discussionmentioning

confidence: 99%

Quality of life in bladder cancer patients receiving medical oncological treatment; a systematic review of the literature

Taarnhøj

Johansen

Pappot

2019

Health Qual Life Outcomes

View full text Add to dashboard Cite

BackgroundPrevious quality of life (QoL) literature in bladder cancer (BC) patients has focused on finding the preferred urinary diversion while little is known about the QoL of patients in medical oncological treatment (MOT). We performed a systematic review to assess the existing literature on QoL in patients with muscle-invasive BC (MIBC) undergoing MOT.MethodsA systematic search of Pubmed and Embase was performed. Inclusion criteria were studies containing QoL data for patients undergoing chemo- and/or radiotherapy. We extracted all QoL scorings at different time intervals and on the six most prevalent domains: overall QoL, urinary, bowel sexual symptoms, pain and fatigue. The study was carried out according to PRISMA guidelines for systematic reviews and GRADE was used to rate the quality of evidence from the included studies.ResultsOf 208 papers reviewed, 21 papers were included. Twenty-one different QoL instruments were applied. The only data on QoL during chemotherapy was from patients in clinical trials investigating new treatments. No studies were found for patients in neoadjuvant treatment. The level of evidence at each time point was graded as very low to moderate. From the studies included the overall QoL seemed inversely related to the organ-specific impairment from sexual and urinary symptoms and increased with decreasing organ-specific symptoms for long term survivors > 6 months after treatment.ConclusionsCollection of data on QoL from patients with MIBC disease undergoing MOT has been sparse and diverse. The present data can act as a summary but prompts for more prospective collection of QoL data from BC patients.Electronic supplementary materialThe online version of this article (10.1186/s12955-018-1077-6) contains supplementary material, which is available to authorized users.

show abstract

Section: Discussionmentioning

confidence: 99%

Quality of life in bladder cancer patients receiving medical oncological treatment; a systematic review of the literature

Taarnhøj

Johansen

Pappot

2019

Health Qual Life Outcomes

View full text Add to dashboard Cite

show abstract

“…Awareness of the diagnosis is a factor that is worth investigating in future research, as previous researchers found that it can reduce anxiety and depression [66]. Referring to recent literature, another important factor that affects QoL is family sharing, which has not been evaluated [67]. Finally, the identification of permanent changes in psychological suffering might require a longer period of monitoring and assessment than 18 months.…”

Section: Discussionmentioning

confidence: 99%

What contributes to long-term quality of life in breast cancer patients who are undergoing surgery? Results of a multidimensional study

et al. 2017

View full text Add to dashboard Cite

show abstract

“…Despite a lack of attention to treatment information sharing between patients with ESKD and their family members, research in other illness populations has shown that patients who feel more able to share information about their illness with family members report better quality of life. 44 Additionally, both patients’ and care partners’ perceptions of the extent to which their family avoids talking about illness affects their own mental health and quality of life. 45 Therefore, ESKD treatment-related information sharing and communication within families may be a fruitful avenue for future research and intervention.…”

Section: Discussionmentioning

confidence: 99%

Family Members’ Experiences With Dialysis and Kidney Transplantation

et al. 2019

View full text Add to dashboard Cite

Rationale & Objective Understanding whether family members’ experiences with patients’ treatment for end-stage kidney disease (ESKD) were expected could guide the development of family-centered interventions that enhance the preparedness of patients and their care partners for kidney replacement therapies. We explored unexpected negative experiences with ESKD treatments among family members of dialysis and posttransplantation patients to identify meaningful directions for family-centered research and clinical care. Study Design Qualitative study. Setting & Participants 8 focus groups comprising 49 family members of dialysis patients and living donor kidney transplant recipients undergoing medical care in Baltimore, MD. Analytical Approach Focus groups were stratified by patients’ treatment (in-center hemodialysis, home hemodialysis, peritoneal dialysis, or living donor kidney transplantation) and family members’ self-reported race (African American vs non–African American), resulting in 2 groups per treatment experience. Inductive thematic analysis was used to identify themes in focus group transcripts. Themes shared across different treatment groups were highlighted to provide insight into common experiences. Results We identified 4 themes that described family members’ unexpected negative treatment experiences: becoming a care partner (unanticipated responsibilities and sleep disruptions), adverse psychological treatment responses in patients (eg, depression) and family members (eg, anxiety), treatment delivery and logistics (insufficient information, medication regimen, and logistical inconveniences), and patient morbidity (dialysis-related health problems and fatigue). All themes were relevant to discussions in the in-center hemodialysis, peritoneal dialysis, and transplantation groups, whereas psychological responses and morbidity themes did not reflect discussions in home hemodialysis groups. Limitations Data collection occurred from 2008 to 2009; family members were recruited through patients undergoing care in 1 geographic area; 1 family member participant per patient. Conclusions Family members described a broad range of unexpected negative experiences with ESKD treatments. Efforts to prepare families for ESKD treatments through more family-centered care, early and tailored education, and interventions targeting care partner preparedness, health provider–family member communication, and relationship dynamics in family member–patient dyads are needed.

show abstract

Sharing information about cancer with one's family is associated with improved quality of life

Cited by 11 publications

References 38 publications

Quality of life in bladder cancer patients receiving medical oncological treatment; a systematic review of the literature

Quality of life in bladder cancer patients receiving medical oncological treatment; a systematic review of the literature

What contributes to long-term quality of life in breast cancer patients who are undergoing surgery? Results of a multidimensional study

Family Members’ Experiences With Dialysis and Kidney Transplantation

Contact Info

Product

Resources

About